nach oben

International Urogynecology Journal

Erschienen in:

02.10.2021 | Original Article

How do women with interstitial cystitis/bladder pain syndrome make treatment choices?

verfasst von: Daisy Hassani, Lorraine Flick, Hareena Sangha, Lily A. Brown, Uduak Andy, Lily Arya

Erschienen in: International Urogynecology Journal | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

There is a relative lack of data regarding how patients weigh various factors when choosing a treatment strategy for interstitial cystitis/bladder pain syndrome (IC/BPS). Our aim is to describe patient experience with their current and prior treatments and discuss factors they consider when choosing a treatment.

Methods

Twenty-one women with IC/BPS participated in five focus groups moderated by a psychologist. Focus groups were conducted until thematic saturation was reached. Group discussions were transcribed and independently coded by two reviewers. Emergent themes and concepts were identified using grounded theory methodology. Data on symptoms and beliefs regarding medications were collected using validated questionnaires: Interstitial Cystitis Symptom and Problem Index (ICSI and ICPI) and Beliefs in Medications Questionnaire-Specific (BMQ-S).

Results

The median age of participants was 42 years, and all had some college education. Median score (range) for the ICSI was 12 (4, 20) and for the ICPI was 10 (3, 16), indicating moderate symptom burden. Most patients had tried only first- or second-line treatments. The median BMQ-S score was 2, indicating a neutral attitude toward medication. Several themes were identified. Patients expressed interest in self-management of symptoms using a structured care plan that incorporates guided self-care practices and care that can be delivered virtually. Patients desired to minimize treatment side effects by reducing prescription medications and avoiding surgical procedures. Finally, patients had considerable interest in alternative treatments; however, they wanted these treatments to be evidence-based.

Conclusions

Women with IC/BPS have a strong interest in guided programs that teach self-care practices and deliver alternative treatments through remote platforms.

Nur mit Berechtigung zugänglich

Hanno PM, Erickson D, Moldwin R, Faraday MM, American Urological A. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–53. https://doi.org/10.1016/j.juro.2015.01.086.CrossRefPubMed

McLennan MT. Interstitial cystitis: epidemiology, pathophysiology, and clinical presentation. Obstet Gynecol Clin N Am. 2014;41(3):385–95. https://doi.org/10.1016/j.ogc.2014.05.004.CrossRef

Michael YL, Kawachi I, Stampfer MJ, Colditz GA, Curhan GC. Quality of life among women with interstitial cystitis. J Urol. 2000;164(2):423–7.CrossRef

Rothrock NE, Lutgendorf SK, Hoffman A, Kreder KJ. Depressive symptoms and quality of life in patients with interstitial cystitis. J Urol. 2002;167(4):1763–7.CrossRef

Clemens JQ, Meenan RT, Rosetti MC, Kimes T, Calhoun EA. Costs of interstitial cystitis in a managed care population. Urology. 2008;71(5):776–80; discussion 780-771. https://doi.org/10.1016/j.urology.2007.11.154.CrossRefPubMed

Bosch PC. Examination of the significant placebo effect in the treatment of interstitial cystitis/bladder pain syndrome. Urology. 2014;84(2):321–6. https://doi.org/10.1016/j.urology.2014.04.011.CrossRefPubMed

Bosch PC, Bosch DC. Treating interstitial cystitis/bladder pain syndrome as a chronic disease. Rev Urol. 2014;16(2):83–7.PubMedPubMedCentral

Kirkham A, Swainston K. Women's experiences of interstitial cystitis/painful bladder syndrome. West J Nurs Res. 2021;193945921990730. https://doi.org/10.1177/0193945921990730.

Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, Forrest JB, Gordon B, Gray M, Mayer RD, Newman D, Nyberg L Jr, Payne CK, Wesselmann U, Faraday MM, Interstitial Cystitis Guidelines Panel of the American Urological Association E, Research I. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70. https://doi.org/10.1016/j.juro.2011.03.064.CrossRefPubMed

10.

Foster HE Jr, Hanno PM, Nickel JC, Payne CK, Mayer RD, Burks DA, Yang CC, Chai TC, Kreder KJ, Peters KM, Lukacz ES, MP FG, Cen L, Landis JR, Propert KJ, Yang W, Kusek JW, Nyberg LM, Interstitial Cystitis Collaborative Research N. Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome. J Urol. 2010;183(5):1853–8. https://doi.org/10.1016/j.juro.2009.12.106.CrossRefPubMedPubMedCentral

11.

Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington (DC): National Academies Press (US). 2001

12.

Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, Lapidus J, Vollmer WM, Better Outcomes of Asthma Treatment Study G. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–77. https://doi.org/10.1164/rccm.200906-0907OC.CrossRefPubMed

13.

Shay LA, Lafata JE. Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Mak. 2015;35(1):114–31. https://doi.org/10.1177/0272989X14551638.CrossRef

14.

Frantsve LM, Kerns RD. Patient-provider interactions in the management of chronic pain: current findings within the context of shared medical decision making. Pain Med. 2007;8(1):25–35. https://doi.org/10.1111/j.1526-4637.2007.00250.x.CrossRefPubMed

15.

Kanter G, Volpe KA, Dunivan GC, Cichowski SB, Jeppson PC, Rogers RG, Komesu YM. Important role of physicians in addressing psychological aspects of interstitial cystitis/bladder pain syndrome (IC/BPS): a qualitative analysis. Int Urogynecol J. 2017;28(2):249–56. https://doi.org/10.1007/s00192-016-3109-2.CrossRefPubMed

16.

Chen HC, Liu CY, Liao CH, Tsao LI. Self-perception of symptoms, medical help seeking, and self-help strategies of women with interstitial cystitis/painful bladder syndrome. Low Urin Tract Symptoms. 2020;12(3):183–9. https://doi.org/10.1111/luts.12300.CrossRefPubMed

17.

McKernan LC, Bonnet KR, Finn MTM, Williams DA, Bruehl S, Reynolds WS, Clauw D, Dmochowski RR, Schlundt DG, Crofford LJ. Qualitative analysis of treatment needs in interstitial cystitis/bladder pain syndrome: implications for intervention. Can J Pain. 2020;4(1):181–98. https://doi.org/10.1080/24740527.2020.1785854.CrossRefPubMedPubMedCentral

18.

O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997;49(5A Suppl):58–63. https://doi.org/10.1016/s0090-4295(99)80333-1.CrossRefPubMed

19.

Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–67. https://doi.org/10.1016/s0022-3999(99)00057-4.CrossRefPubMed

20.

Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999;14(1):24. https://doi.org/10.1080/08870449908407311.

21.

Digard JP. The discovery of grounded theory. Strategies for qualitative research. Homme 2011;(198–99):377–380

22.

Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1–7. https://doi.org/10.1207/S15324796ABM2601_01.CrossRefPubMed

23.

Nicholas MK, Asghari A, Blyth FM, Wood BM, Murray R, McCabe R, Brnabic A, Beeston L, Corbett M, Sherrington C, Overton S. Self-management intervention for chronic pain in older adults: a randomised controlled trial. Pain. 2013;154(6):824–35. https://doi.org/10.1016/j.pain.2013.02.009.CrossRefPubMed

24.

Damush TM, Kroenke K, Bair MJ, Wu J, Tu W, Krebs EE, Poleshuck E. Pain self-management training increases self-efficacy, self-management behaviours and pain and depression outcomes. Eur J Pain. 2016;20(7):1070–8. https://doi.org/10.1002/ejp.830.CrossRefPubMed

25.

Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JAJ, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;35(6):502–14. https://doi.org/10.1002/da.22728.CrossRefPubMedPubMedCentral

26.

Cherkin DC, Sherman KJ, Balderson BH, Cook AJ, Anderson ML, Hawkes RJ, Hansen KE, Turner JA. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA. 2016;315(12):1240–9. https://doi.org/10.1001/jama.2016.2323.CrossRefPubMedPubMedCentral

27.

Rose G. Why do patients with rheumatoid arthritis use complementary therapies? Musculoskeletal Care. 2006;4(2):101–15. https://doi.org/10.1002/msc.82.CrossRefPubMed

28.

Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998;279(19):1548–53. https://doi.org/10.1001/jama.279.19.1548.CrossRefPubMed

Titel: How do women with interstitial cystitis/bladder pain syndrome make treatment choices?
verfasst von: Daisy Hassani
Lorraine Flick
Hareena Sangha
Lily A. Brown
Uduak Andy
Lily Arya
Publikationsdatum: 02.10.2021
Verlag: Springer International Publishing
Erschienen in: International Urogynecology Journal / Ausgabe 3/2022
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-021-04994-6

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Internistische Arzneimitteltherapie Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

How do women with interstitial cystitis/bladder pain syndrome make treatment choices?

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Blutdrucksenkung könnte Uterusmyome verhindern

Update Gynäkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Psychological intervention in women with Mayer-Rokitansky-Küster-Hauser syndrome after artificial vaginoplasty: a prospective study

The effect of preoperative phenazopyridine on short-term urinary retention following urogynecologic surgery

Surgical interventions in female urethral strictures: a comprehensive literature review

Urethral support in female urinary continence part 1: dynamic measurements of urethral shape and motion

Quality of life is improved after urethroplasty in women with urethral stricture

Effectiveness of physiotherapy for lower urinary tract symptoms in postpartum women: systematic review and meta-analysis

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Blutdrucksenkung könnte Uterusmyome verhindern

Update Gynäkologie